Insul 30/70 biosimilar (Popular Pharmaceuticals)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsul 30/70 biosimilar (Popular Pharmaceuticals)
Drug Alias NameInsul 30-70
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes, Gestational
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPopular Pharmaceuticals Plc
China Registration ClassN/A

Develop Information

Active CompaniesPopular Pharmaceuticals Plc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes, Gestational
Inactive IndicationsN/A

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A